Literature DB >> 9403365

Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse.

C Ghelardini1, N Galeotti, M Nicolodi, S Donaldson, F Sicuteri, A Bartolini.   

Abstract

The antinociceptive effect of the antimigraine drug sumatriptan was assessed in mice (hot-plate and abdominal constriction tests). Antinociception induced by sumatriptan (10-30 mg kg-1 i.p.) was prevented by the muscarinic antagonist atropine (5 mg kg-1 i.p.), the ACh-depletor hemicolinium-3 (1 microgram per mouse i.c.v.) and the 5-HT1A antagonist NAN-190 (0.5 mg kg-1 i.p.). Naloxone, CGP-35348 and reserpine administered in doses suitable for blocking analgesia respectively induced by morphine, baclofen and clomipramine did not modify sumatriptan antinociception. On the basis of the above findings, we can deduce that sumatriptan was able to induce antinociception by increasing cholinergic neurotransmission through the stimulation of 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403365

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  3 in total

1.  Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan.

Authors:  Louis P Vera-Portocarrero; Michael H Ossipov; Tamara King; Frank Porreca
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

2.  Both endogenous and exogenous ACh plays antinociceptive role in the hippocampus CA1 of rats.

Authors:  X F Yang; Y Xiao; M-Y Xu
Journal:  J Neural Transm (Vienna)       Date:  2007-09-14       Impact factor: 3.575

3.  Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan.

Authors:  Tetsuro Nikai; Allan I Basbaum; Andrew H Ahn
Journal:  Pain       Date:  2008-08-23       Impact factor: 6.961

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.